Marc B Garnick MDDirector of Cancer Community Services, Network Development, BIDMC; the Gorman Brothers Professor of Medicine at Harvard Medical School (HMS)
Dr. Garnick is a physician in the Division of Hematology/Oncologyof the Cancer Center at Beth Israel Deaconess Medical Center (BIDMC); serves as Director of Cancer Community Services, Network Development, BIDMC; is the Gorman Brothers Professor of Medicine at Harvard Medical School(HMS) and serves as a special advisor to the Oncologic Drugs Advisory Committee of the FDA.
Dr. Garnick is a world-renowned clinician and clinical investigator in prostate cancer and other urologic cancers. At BIDMC, he founded the Hershey Family Program for Prostate Cancer Research. Dr. Garnick is also involved in the development of oncologic products through biotechnology. He has made it his personal mission to help patients navigate the maze of treatment options to help them make informed decisions. Dr. Garnick is editor-in-chief of The Annual Report on Prostate Diseases, Harvard Medical School’s award-winning publication and authored “The Patient’s Guide to Prostate Cancer.”
Relevant disclosures: Member scientific advisory board of Myovant Sciences; shareholder in Myovant Science; former member Ferring scientific advisory board; receive honoraria for serving as editor of HMS Annual Report on Prostate Diseases; special government employee and member of several Oncology Drug Advisory Committees of FDA.